Latest news
Loading news…
Artielle ImmunoTherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). San Mateo, California, United States Founded 2004 1-10 employees For Profit
Artielle ImmunoTherapeutics develops recombinant T-cell receptor ligands to treat T-cell-mediated inflammatory diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 3
- IT spend
- $441K
Company Info
- Founded
- 2004
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 1
- HQ
- San Mateo, California, United States
- Region
- San Francisco Bay Area, Silicon Valley, West Coast
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- 0
- Trend (30d)
- 3.6
- Trend (90d)
- 3.7
Key People at Artielle ImmunoTherapeutics
Chairman&CEO
Director and Secretary
Director
Director
Founding Scientist
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Artielle ImmunoTherapeutics
Loading news…
FAQs about Artielle ImmunoTherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.